The mRNA Survival Test: Arcturus Therapeutics Bets on Inhaled Cystic Fibrosis Therapy After COVID Revenue Collapse
On a September morning in 2025, Arcturus Therapeutics filed a lawsuit against two larger companies — a defensive move that signaled just how much the biotech la…